logo
Select company
Select metric
$ 6.44MNet Cash Flow - Financing
VS
Market
36
Sector
50
Industry
60
History
10
$ 3.35Close
$ 2.28 - $ 11.2 52-Week Range
Ticker Information

Ticker

PTIX

Company Name

PROTAGENIC THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROTAGENIC THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PTIX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 6.44M
3/31/2025$ 2.02M
12/31/2024$ 1.96M
9/30/2024$ 316.96K
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTAGENIC THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 1.22M.
  • Over the past 5 years, PROTAGENIC THERAPEUTICS INC's average CF - Financing has been $ 3.24M.
  • The median CF - Financing for PROTAGENIC THERAPEUTICS INC during this period was $ 668.75K
  • PROTAGENIC THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 12.9M.
  • The lowest CF - Financing recorded by PROTAGENIC THERAPEUTICS INC in the same timeframe $ 0

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

PTIX - Net Cash Flow - Financing, Last 5 years

$ 0

Minimum

Jun 30, 2022

$ 12.9M

Maximum

Jun 30, 2021

$ 3.24M

Average

$ 668.75K

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M